CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Exact Sciences

Federica Rebagliati, Sr. Compliance Manager, International

Business Success Through Compliance

Federica Rebagliati

Federica Rebagliati

A seasoned and passionate professional with nearly two decades of experience in the healthcare industry and compliance, Federica Rebagliati, is an accomplished leader renowned for her strategic acumen and adept management of intricate projects. Her distinct skill set encompasses medical affairs, marketing, market access, compliance, and patient advocacy, showcasing a robust background. Rebagliati’s keen eye for risk assessment, creative and analytical approach, and organizational mindset, consistently deliver innovative solutions through end-to-end project management. Her perseverance in facing challenges, commitment to surpassing average expectations, and desire for continuous self-improvement further define Rebagliati’s professional character. Currently, she serves as Sr. Compliance Manager, International at Exact Sciences.


Please share with our readers your career journey.


I have a solid background of almost two decades in the healthcare sector, primarily in the pharmaceutical industry. And recently I have transitioned into the medical devices arena. Throughout this two-decade journey, I have served in various roles across different functions, including medical operations, marketing operations, patient advocacy, and market access. This diverse experience has provided me with a comprehensive understanding of the business, offering insights into the practical realities of the healthcare world. In my previous company, my varied background caught the attention of the compliance team. Recognizing my background in business as well as having a heterogeneous yet authentic understanding of the industry, I became a bridge between compliance and the business, ensuring effective communication and collaboration. This distinct background in various arenas took me to the realm of compliance.


Can you share some of the challenges you notice in the industry?


In my experience, around a decade ago, engaging with the compliance manager was often accompanied by fear – fear of judgment, and fear of making mistakes. However, the dynamics have significantly evolved since then. Compliance has transitioned into a more collaborative role, serving as a partner that fosters an increased dialogue between compliance and the business. It is no longer someone to be feared rather it is someone that helps build business. The key challenge, as I see it, arises when there is a lack of trust between the business and compliance. Without trust, meaningful dialogue becomes difficult, impeding the development of a true partnership. Building a culture of trust and compliance within the company is crucial to establishing a positive relationship.


Could you explain how you approach a new business with a new initiative?


I believe trust is a significant factor in a business and so I encourage business owners to share details about their initiatives, even in their early stages when they might be embryonic and not fully defined. We begin with understanding needs, objectives, and key performance indicators. During the discussion, we create a space for an open dialogue about the genuine needs they aim to address.


It is more of a brainstorming session where I constructively challenge the idea, not the individual. The intent is never to hinder the initiative but to guarantee that the business owner has considered all aspects. Following this, we initiate a discussion to identify potential operational, regulatory, and reputational risks associated with the initiative. Simultaneously, we engage in a cross-functional evaluation to outline a comprehensive mitigation plan. This cross-functional discussion is crucial for ensuring the business is approached in the right way.


How do you envision the future of this industry?


Compliance spans various domains, and I would delve into three key areas of focus. First, AI. Beyond the compliance perspective, the ethical implications of AI are profound and transformative in our lives.  Compliance plays a pivotal role in offering guidance on the development of AI tools. However, the crucial question at this point is which AI tools are ethically sustainable. Before delving into practical applications, it's imperative to thoroughly understand the ethical foundations of AI tools.


My advice to someone entering the field of compliance is to avoid making assumptions. Instead, ask questions without preconceived judgments and listen attentively to the business needs without anticipating them. And at last, constructive


The second is cybersecurity which still remains a perpetual concern. Due to the ever-evolving landscape of technology, a continuous focus on it is necessary. As a result, being compliance professionals, our role is to proactively prevent data breaches, secure remote access to company systems, and safeguard data privacy and corporate security.


The third is corporate sustainability due diligence. It is our responsibility to recognize our individual and company's responsibilities both morally and legally to assess the impact we have on human rights and the environment.


What is your piece of advice to your fellow peers?


The compliance manager is the enabler that supports business in executing the right actions in the right manner. As a result, they must stay abreast of new trends, especially in the realm of digital activities. It's crucial to be consistently aligned to identify potential areas of non-compliance or ethical risks, enabling the evaluation of business operations and initiatives to assess and mitigate risks. In a nutshell, my advice to a colleague or someone entering the field of compliance is to avoid making assumptions. Instead, ask questions without preconceived judgments and listen attentively to the business needs without anticipating them. And at last, constructively challenge the ideas, but not the people.


 


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/leadership-perspective/business-success-through-compliance-nwid-1704.html